Skip to main content Accessibility help
×
Home

Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases

  • E. McLEAN (a1), R. G. PEBODY (a1), C. CAMPBELL (a1), M. CHAMBERLAND (a1), C. HAWKINS (a1), J. S. NGUYEN-VAN-TAM (a2), I. OLIVER (a3), G. E. SMITH (a3), C. IHEKWEAZU (a3), S. BRACEBRIDGE (a3), H. MAGUIRE (a3), R. HARRIS (a1), G. KAFATOS (a1), P. J. WHITE (a1) (a4), E. WYNNE-EVANS (a1), J. GREEN (a1), R. MYERS (a1), A. UNDERWOOD (a1), T. DALLMAN (a1), T. WREGHITT (a5), M. ZAMBON (a1), J. ELLIS (a1), N. PHIN (a1), B. SMYTH (a6), J. McMENAMIN (a7) and J. M. WATSON (a1)...

Summary

The UK was one of few European countries to document a substantial wave of pandemic (H1N1) 2009 influenza in summer 2009. The First Few Hundred (FF100) project ran from April–June 2009 gathering information on early laboratory-confirmed cases across the UK. In total, 392 confirmed cases were followed up. Children were predominantly affected (median age 15 years, IQR 10–27). Symptoms were mild and similar to seasonal influenza, with the exception of diarrhoea, which was reported by 27%. Eleven per cent of all cases had an underlying medical condition, similar to the general population. The majority (92%) were treated with antiviral drugs with 12% reporting adverse effects, mainly nausea and other gastrointestinal complaints. Duration of illness was significantly shorter when antivirals were given within 48 h of onset (median 5 vs. 9 days, P=0·01). No patients died, although 14 were hospitalized, of whom three required mechanical ventilation. The FF100 identified key clinical and epidemiological characteristics of infection with this novel virus in near real-time.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Dr R. Pebody, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London, NW9 5EQ. (Email: Richard.Pebody@hpa.org.uk)

References

Hide All
1.Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children – Southern California, March–April 2009. Morbidity and Mortality Weekly Report 2009; 58: 400402.
2.Centers for Disease Control and Prevention. Outbreak of swine-origin influenza A (H1N1) virus infection – Mexico, March–April 2009. Morbidity and Mortality Weekly Report 2009; 58: 467470.
3.Garten, RJ, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325: 197201.
4.Health Protection Agency. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Eurosurveillance 2009; 14: pii=19232.
5.Health Protection Agency. Epidemiology of new influenza A(H1N1) in the United Kingdom, April–May 2009. Eurosurveillance 2009; 14: pii=19213.
6.Health Protection Agency. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave, 24 November 2009 (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1258560552857). Accessed 4 December 2009.
7.World Health Organization. Global surveillance during an influenza pandemic (http://www.who.int/csr/disease/swineflu/global_pandemic_influenza_surveilance_apr09.pdf). Accessed 15 February 2010.
8.McMenamin, J, et al. Minimum dataset for confirmed human cases of influenza H5N1. Lancet 2008; 372: 2022.
9.Health Protection Agency. The First Few Hundred (FF100) Project. Epidemiological Protocols for Comprehensive Assessment of Early Swine Influenza Cases in the United Kingdom, 2009 (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1257260453727). Accessed 4 December 2009.
10.Gates, P, et al. Collection of routine national seasonal influenza vaccine coverage data from GP practices in England using a web-based collection system. Vaccine 2009; 27: 66696677.
11.National Centre for Social Research. National Survey of Sexual Attitudes and Lifestyles II, 2000–2001. 2005.
12.Ellis, J, Curran, M. Simultaneous molecular detection and confirmation of influenza AH5, with internal control. In: Stephenson, JR, Warnes, A, eds. Diagnostic Virology Protocols. Humana Press (in press).
13.Ellis, J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Eurosurveillance 2009; 14: pii=19230.
14.Calatayud, L, et al. Pandemic (H1N1) 2009 virus outbreak in a school in London, April–May 2009: an observational study. Epidemiology and Infection 2009; 138: 183191.
15.Health Protection Agency West Midlands H1N1v Investigation Team. Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009. Eurosurveillance 2009; 14: pii=19264.
16.Kar-Purkayastha, I, et al. The importance of school and social activities in the transmission of influenza A(H1N1)v: England, April–June 2009. Eurosurveillance 2009; 14: pii=19311.
17.Begum, F, Pebody, RG.Influenza vaccine uptake among the 65 years and over and under 65 years at risk in England, winter season 2008–09. 2009 (http://www.immunisation.nhs.uk/publications/FluVaccineUptake_Winter0809.pdf). Accessed 4 December 2009.
18.Ghani, AC, et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Currents: Influenza 2009; RRN1130.
19.Dawood, FS, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England Journal of Medicine 2009; 360: 26052615.
20.Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morbidity and Mortality Weekly Report 2009; 58: 521524.
21.Miller, E, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375: 11001108.
22.Nicholson, KG. Clinical features of influenza. Seminars in Respiratory Infections 1992; 7: 2637.
23.Presanis, AM, et al. The severity of pandemic H1N1 influenza in the United States, April–July 2009. PLoS Currents: Influenza 2009; RRN1042.
24.National Institute for Health and Clinical Excellence. Amantadine, oseltamivir and zanamivir for the treatment of influenza. Review of NICE technology appraisal guidance 58, 2009 (http://www.nice.org.uk/nicemedia/pdf/TA168fullguidance.pdf). Accessed 4 December 2009.
25.Aoki, FY, Boivin, G. Influenza virus shedding: excretion patterns and effects of antiviral treatment. Journal of Clinical Virology 2009; 44: 255261.
26.Donaldson, LJ, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. British Medical Journal 2009; 339: b5213.

Keywords

Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases

  • E. McLEAN (a1), R. G. PEBODY (a1), C. CAMPBELL (a1), M. CHAMBERLAND (a1), C. HAWKINS (a1), J. S. NGUYEN-VAN-TAM (a2), I. OLIVER (a3), G. E. SMITH (a3), C. IHEKWEAZU (a3), S. BRACEBRIDGE (a3), H. MAGUIRE (a3), R. HARRIS (a1), G. KAFATOS (a1), P. J. WHITE (a1) (a4), E. WYNNE-EVANS (a1), J. GREEN (a1), R. MYERS (a1), A. UNDERWOOD (a1), T. DALLMAN (a1), T. WREGHITT (a5), M. ZAMBON (a1), J. ELLIS (a1), N. PHIN (a1), B. SMYTH (a6), J. McMENAMIN (a7) and J. M. WATSON (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed